drugset
drugset / Trial / NCT02937181

Antibiotic Prophylaxis in Open Fractures

NCT02937181 ↗

Phase 4 Unknown 50 enrolled Olayemi Osiyemi MD Forest Laboratories · collab
NaSingle-groupOpen-labelTreatment

Summary

Prospective look at antibiotic prophylaxis with Ceftaroline in patients with type II and III open fractures

Timeline

Start
2016-12
Primary completion
2018-10
Completion
2019-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftaroline Other / unclassified — Intravenous

Indications

No indication recorded.